Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Tango Therapeutics Inc’s stock clocked out at $2.07, down -9.61% from its previous closing price of $2.29. In other words, the price has decreased by -$9.61 from its previous closing price. On the day, 15.63 million shares were traded. TNGX stock price reached its highest trading level at $3.0 during the session, while it also had its lowest trading level at $2.07.
Ratios:
To gain a deeper understanding of TNGX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.26 and its Current Ratio is at 6.26. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.20.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on July 17, 2024, initiated with a Buy rating and assigned the stock a target price of $19.
On February 12, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $18.Piper Sandler initiated its Overweight rating on February 12, 2024, with a $18 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 04 ’25 when Barry Douglas sold 2,774 shares for $2.99 per share. The transaction valued at 8,289 led to the insider holds 68,570 shares of the business.
Barry Douglas sold 2,556 shares of TNGX for $8,081 on Feb 05 ’25. The General Counsel now owns 66,014 shares after completing the transaction at $3.16 per share. On Feb 04 ’25, another insider, Beckman Daniella, who serves as the Chief Financial Officer of the company, sold 4,284 shares for $2.99 each. As a result, the insider received 12,801 and left with 154,232 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNGX now has a Market Capitalization of 224375568 and an Enterprise Value of 44597972. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.47 while its Price-to-Book (P/B) ratio in mrq is 1.34. Its current Enterprise Value per Revenue stands at 1.088 whereas that against EBITDA is -0.311.
Stock Price History:
The Beta on a monthly basis for TNGX is 1.30, which has changed by -0.7198918 over the last 52 weeks, in comparison to a change of 0.11936104 over the same period for the S&P500. Over the past 52 weeks, TNGX has reached a high of $12.02, while it has fallen to a 52-week low of $1.03. The 50-Day Moving Average of the stock is 38.11%, while the 200-Day Moving Average is calculated to be -53.29%.
Shares Statistics:
It appears that TNGX traded 1.12M shares on average per day over the past three months and 4529510 shares per day over the past ten days. A total of 108.11M shares are outstanding, with a floating share count of 58.92M. Insiders hold about 45.64% of the company’s shares, while institutions hold 55.83% stake in the company. Shares short for TNGX as of 1745971200 were 12554952 with a Short Ratio of 11.24, compared to 1743379200 on 10042724. Therefore, it implies a Short% of Shares Outstanding of 12554952 and a Short% of Float of 14.02.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
